Completed PHASE1 INTERVENTIONAL 1-arm NCT02307656

Taste Properties of Atazanavir and Cobicistat

Assessment of the Taste Properties of Atazanavir and Cobicistat and Pediatric Oral Test Formulations Containing Both Atazanavir and Cobicistat in Healthy Adults

Sponsor: Bristol-Myers Squibb

Conditions HIV in Adults

Interventions Active Pharmaceutical Ingredient Atazanavir Cobicistat

Updated 10 times since 2017 Last updated: Dec 15, 2021 Started: Dec 12, 2014 Primary completion: Sep 9, 2021 Completion: Sep 9, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02307656, this PHASE1 trial focuses on HIV in Adults and remains completed. Sponsored by Bristol-Myers Squibb, it has been updated 10 times since 2014, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Feb 2022 — Jul 2024 [monthly]

Completed PHASE1

Status: Unknown Status → Completed
Jan 2021 — Feb 2022 [monthly]

Unknown Status PHASE1
Jul 2020 — Jan 2021 [monthly]

Unknown Status PHASE1

Status: Active Not Recruiting → Unknown Status

▶ Show 5 earlier versions

Jul 2018 — Jul 2020 [monthly]

Active Not Recruiting PHASE1
Jun 2018 — Jul 2018 [monthly]

Active Not Recruiting PHASE1
Jul 2017 — Jun 2018 [monthly]

Active Not Recruiting PHASE1
Feb 2017 — Jul 2017 [monthly]

Active Not Recruiting PHASE1
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting PHASE1

First recorded

Dec 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bristol-Myers Squibb

Data source: Bristol-Myers Squibb

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Woburn, United States